TRS 961 (2011) – Appendix 6 – WHO GMP for sterile pharmaceuticals


In the process of implementing the World Health Organization’s (WHO) Good Drug Manufacturing Practice (GMP) guidelines within the framework of the WHO Pre-Evaluation Program, a number of changes have been proposed and implemented. For ease of follow-up, this full guide has been republished as an appendix to the latest report by the WHO Expert Council on Pharmaceutical Standards.

See the full contents of the appendix at: Good practice of producing sterile pharmaceuticals